JEVTANA(R) (Cabazitaxel) Is Now Available In The UK For The Treatment Of Men With Advanced Prostate Cancer Resistant To Other Therapy
7/04/2011

Sanofi-aventis announced today that it has launched JEVTANA in combination with prednisone/prednisolone for the treatment of men with mHRPC previously treated with docetaxel. Men with this stage of cancer typically have a poor prognosis and until now, there have been no licensed treatments available to extend life...

Aflibercept Significantly Improves Survival In Previously Treated Metastatic Colorectal Cancer Patients
7/04/2011

Sanofi-aventis and Regeneron Pharmaceuticals, Inc. announced data on Saturday 25 June showing that the investigational agent aflibercept, also known as VEGF Trap, significantly improved survival in previously treated metastatic colorectal (bowel) cancer patients.1 These data were presented at the ESMO World Congress on Gastrointestinal Cancer in Barcelona, Spain...

Nycomed's Instanyl (Fentanyl) Single-Dose Nasal Spray Receives European Approval
7/04/2011

Nycomed today announced that the European Commission has granted marketing authorisation for its Instanyl single-dose nasal spray. The single-dose nasal spray marks another innovation by Nycomed in the management of breakthrough pain in cancer patients and will be available in European countries from September 2011. Instanyl fentanyl nasal spray has been developed by Nycomed...

Researchers Test Benefit Of Fish Oil In Bowel Cancer Spread
7/04/2011

Researchers from the University of Leeds will carry out a series of experiments to see whether fish oil can prevent or treat the spread of bowel cancer to the liver...

New Class Of Antiangiogenesis Drugs Identified
7/04/2011

Massachusetts General Hospital (MGH) researchers have discovered the first of an entirely new class of antiangiogenesis drugs - agents that interfere with the development of blood vessels...

The Importance Of Breast Cancer Screening Should Be Emphasized By Health Providers
7/04/2011

Wayne State University researchers believe medical practitioners can help reduce the number of breast cancer deaths among low-income African-American women by more effectively educating their patients about the importance of mammography screening. In a study published this month in the Journal of Cancer Education, Rosalie Young, Ph.D., associate professor; Kendra Schwartz, M.D., M.S.P.H...

Racial Disparities In Emergency Stroke Treatment
7/04/2011

A citywide study published online in Stroke: Journal of the American Heart Association demonstrates racial disparities in the use of clot-busting drugs to treat acute ischemic stroke, the most common type of stroke...

Fluorescent Fish Could Hold The Key To Understanding Diabetes And Other Diseases
7/03/2011

Scientists from Queen Mary, University of London have discovered a new way of detecting zinc in zebra fish, that could pave the way for furthering our understanding of diseases like type 2 diabetes, prostate cancer and Alzheimer's. The results will be announced today (3 July) at the Sixth International Symposium on Macrocyclic and Supramolecular Chemistry, in Brighton...

News From The Journal Of Clinical Investigation: July 1, 2011
7/03/2011

ONCOLOGY: Role for stem cells in tumor development Ovarian cancer is the fifth most common cancer among women. New research, performed by Ronald Buckanovich and colleagues, at the University of Michigan Medical Center, Ann Arbor, provides insight into the cellular and molecular mechanisms that promote ovarian tumor development and thereby identifies a potential new therapeutic approach...

Mobile Phone Cancer Link Looking Less And Less Likely
7/03/2011

Evidence from a growing number of studies does not support the theory that cellphones raise the risk of brain cancer, an independent international panel of experts has found after carrying out a thorough analysis of all published research. The analysis was carried out by the ICNIRP (International Commission on Non-Ionizing Radiation Protection) Standing Committee on Epidemiology...